Expert guidance, every step. Medical solutions personalized, simplified.

  • Home
  • DOCTORS
  • Aigner treatment of cancer in advanced stages

Aigner treatment of cancer in advanced stages

Biography

German Board Certified Surgical Oncologist
40+ Years Clinical Experience

Prof. Dr. med. Karl R. Aigner

Pioneer in Regional Chemotherapy (RCT) & Interventional Oncology

Current Role: Medical Director and Chief Physician, Medias Klinikum Burghausen
Focus: Advanced and Chemoresistant Cancers

Professor Karl R. Aigner received his medical education at Friedrich-Alexander University Erlangen-Nürnberg and specialised in surgery. He has more than 45 years of clinical experience in surgical oncology and has developed techniques involving vascular isolation of organs and regional chemotherapy. At Medias Klinikum Burghausen, his clinical work focuses on interventional and regional oncology, including treatment approaches for advanced cancers and situations in which conventional systemic chemotherapy may no longer provide adequate disease control.

Patient Relevance

Why This Physician May Be Relevant to Your Case

Patients seeking specialist review for advanced solid tumours, regional chemotherapy, isolated organ perfusion, peritoneal disease, or cancer that has not responded adequately to previous systemic treatment may consider an evaluation with Prof. Dr. med. Karl R. Aigner. Individual relevance depends on the diagnosis, available imaging, tumour location and vascular anatomy, previous treatment, and the patient’s overall clinical condition.

Key Areas of Expertise

 

Regional Chemotherapy (RCT)

Regional delivery of cytostatic drugs through arteries supplying the tumor, with treatment directed toward the affected region rather than relying solely on systemic administration.

 

Isolated Organ Perfusion

Surgical isolation of an affected organ or vascular region from systemic circulation to allow concentrated local treatment.

 

Treatment of Advanced and Inoperable Cancer

Specialized regional and interventional approaches for selected advanced tumors, including cases considered difficult to treat with conventional surgery alone.

 

Peritoneal Carcinomatosis

Regional approaches including hypoxic abdominal perfusion for selected patients with advanced peritoneal disease.

 

Organ-Sparing Surgery

Surgical strategies designed to achieve local tumor control while considering preservation of affected organs and function where clinically appropriate.

 

Treatment of Chemoresistant Disease

Regional treatment strategies investigated and used for selected solid tumors that have shown inadequate response to previous systemic treatment.

Clinical Approach

At Medias Klinikum, treatment planning for complex oncology cases involves assessment of the tumor, its vascular accessibility, previous treatments and the patient’s clinical condition. Regional and interventional approaches are considered only when the clinical situation and treatment anatomy make them appropriate.

20,000+
regional chemotherapy treatments since founding

Medias Klinikum Oncology Centre in Burghausen

Medias Klinikum is a specialized oncology hospital in Burghausen, Bavaria, with a clinical focus that includes oncological surgery, regional chemotherapy, electrochemotherapy, immunotherapy and other cancer-treatment approaches.

Professor Aigner serves as Medical Director and Chief Physician.

Scientific Recognition and Expertise

Main Research Focus

Regional Therapy and Isolated Organ Perfusion

Research and clinical work have focused on regional chemotherapy, intra-arterial treatment and isolated organ perfusion techniques in advanced cancer.

Publication / Scientific Area Verified Reference
Intra-arterial chemotherapy PubMed PMID 31506738
Regional chemotherapy PubMed PMID 35877246
Isolated hypoxic abdominal perfusion PubMed Central / PMC6707993

Make an appointment

    By clicking this button, you agree to the processing of personal data